Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia
Key facts
- Who runs it
- Menoufia University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2/3
- People taking part
- 78 people enrolled
- Started
- 24 Jun 2023
- Ended
- 24 Nov 2023
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Povidone-Iodine
- Saline spray
- Record updated
- 27 November 2023
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- on mechanical ventilation less than 24 h after admission and expected to continue mechanical ventilation for more than 72h
Who cannot take part
- Exclusion criteria include immunosuppression, aspiration pneumonia, all types of pneumonia, sepsis and septic shock, tracheostomy, and pregnancy
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
It has been shown that oral hygiene reduces the incidence of ventilator-associated pneumonia (VAP). The nasopharynx is considered to be an important source of contaminated micro aspiration to the lung however, the effect of nasopharyngeal decontamination on VAP has not been yet investigated. The investigators hypothesized that decontamination of oral and nasopharyngeal cavities with combined Povidone Iodine and glycyrrhizin would remarkably reduce the incidence of VAP.
The 2 groups in the trial
- Treatment groupTreatment being tested
Nasal and oropharyngeal Povidone Iodine plus Glycyrrhizin sprays will be applied 4 times daily after tooth cleaning with a brush.
Treatment: Povidone-Iodine
- Placebo groupPlacebo, for comparison
Nasal and oropharyngeal saline sprays will be applied 4 times daily after teeth cleaning with a brush.
Treatment: Saline spray
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Nasal and Oropharyngeal Use of Povidone Iodine and Glycyrrhizin on Ventilator-associated Respiratory Infections: A Randomized Trial
- Record updated
- 27 November 2023